Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

Stuart J PocockJoao Pedro FerreiraMilton PackerFaiez ZannadGerasimos FilippatosToru KondoJohn J V McMurrayScott D SolomonJames L JanuzziTomoko IwataAfshin SalsaliJaved ButlerStefan D Anker

Published in: European journal of heart failure (2022)

The combination of NT-proBNP and hs-cTnT along with a few readily available clinical variables provides effective risk discrimination both for morbidity and mortality in patients with HFpEF. A predictive tool-kit facilitates the ready implementation of these risk models in routine clinical practice.

Keyphrases

clinical practice
healthcare
primary care
clinical trial
study protocol
randomized controlled trial
quality improvement
phase ii
open label